Search results for "antidepressants"

showing 10 items of 22 documents

Associations of neuropsychiatric symptoms and antidepressant prescription with survival in Alzheimer's disease

2017

Objective Depression is associated with increased mortality in community samples. The use of antidepressant medication may also increase mortality, however, it is still unclear whether taking antidepressants before or after a diagnosis of dementia influences survival. Design Retrospective. Setting A cohort with a diagnosis of Alzheimer disease (AD) from a large mental health and dementia care database in South London, linked to hospitalization and mortality data. Participants Mild dementia (Mini-Mental State Examination ≥18/30) at the point of diagnosis. Measurements We ascertained antidepressant prescription, either in the 6 months before or after dementia diagnosis, and used the HoNOS65+,…

Malemedicine.medical_specialtyPediatricsDatabases FactualDementia; antidepressants; depression; mortalityKaplan-Meier EstimateNeuropsychological TestsRisk AssessmentSeverity of Illness Index03 medical and health sciencesSex Factors0302 clinical medicineAlzheimer DiseasemedicineHumansDementia030212 general & internal medicineMedical prescriptionRisk factorPsychiatryGeneral NursingDepression (differential diagnoses)AgedProportional Hazards ModelsRetrospective StudiesAged 80 and overDepressive Disorderbusiness.industryHealth PolicyHazard ratioAge FactorsGeneral MedicineMiddle AgedPrognosismedicine.diseaseSurvival AnalysismortalityAntidepressive AgentsConfidence intervalantidepressantsdepressionCohortFemaleDementiaGeriatrics and GerontologyAlzheimer's diseasebusinessdementia mortality030217 neurology & neurosurgery
researchProduct

Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients.

2019

Depression is often under-recognized in older patients, even if antidepressants (AD) are commonly prescribed, with a prevalence of use that increase with ageing [ 1 ]. Nevertheless, even if a diagnosis of depression is established, inappropriate treatment can occur [ 2 ]. Beers criteria are the most widely screening tools used to detect inappropriate prescription of drugs in people aged 65 years or more [ 3 ]. Since 2010, attempts to adapt the Beers' criteria have been made in Europe [ 4 , 5 ]. Tricyclic drugs are the ADs to be always avoided in the elderly, owing to their anticholinergic side effects, such as cognitive impairment, delirium, urinary retention and falls [ 3 ]. Selective sero…

Malemedicine.medical_specialtySocio-culturaleInappropriate Prescribing-Potentially inappropriate medication olderPractice Patternsdepression hospitalized patients drugselderlydrugsantidepressivi anzianoPolypharmacy | Inappropriate Prescribing | Medications PIMsantidepressant agent escitalopram paroxetineInternal MedicinemedicineHospital dischargeolderEscitalopramHumansLS4_4Medical prescriptionPractice Patterns Physicians'Depression (differential diagnoses)AgedPolypharmacySertralinePhysicians'antidepressantbusiness.industryTrazodonehospitalized patientsAntidepressive AgentsHospitalizationAcute Disease; Aged; Antidepressive Agents; Female; Humans; Inappropriate Prescribing; Italy; Male; Practice Patterns Physicians'; Hospitalizationantidepressants; elderlyItalyantidepressantsEmergency medicinedepressionAcute DiseasePolypharmacy Inappropriate Prescribing Medications PIMDeliriumFemalePotentially inappropriate medicationmedicine.symptombusinessmedicine.drugEuropean journal of internal medicine
researchProduct

Use of antidepressants among Finnish family caregivers : a nationwide register-based study

2021

Abstract Purpose The purpose of this study was to compare the use of antidepressants over 6 years between family caregivers providing high-intensity care and a matched control population using register-based data. Methods The study includes all individuals, who received family caregiver’s allowance in Finland in 2012 (n = 29,846 females, mean age 66 years; n = 12,410 males, mean age 71 years) and a control population matched for age, sex, and municipality of residence (n = 59,141 females; n = 24,477 males). Information on purchases of antidepressants, including the number of defined daily doses (DDD) purchased, between 2012 and 2017 was obtained from the national drugs reimbursement registe…

Maleregisters.Health (social science)Epidemiology3124 Neurology and psychiatry0302 clinical medicinemielenterveysomaishoitajatEpidemiologyMedicine030212 general & internal medicineperhehoitoReimbursementFinlandperhehoitajatinformal caregivingeducation.field_of_studyFamily caregiversRegistersAntidepressantsAntidepressive Agents3142 Public health care science environmental and occupational health3. Good healthPsychiatry and Mental healthCaregiversInformal caregivingantidepressantsFemaleMental healthmental healthmasennusmedicine.medical_specialtySocial PsychologyPopulation03 medical and health sciencesHumanseducationSocioeconomic statusAgedOriginal Paperbusiness.industryMental healthConfidence intervalAgeinglääkkeetikääntyminenSocial ClassageingRelative risklääkehoitobusiness030217 neurology & neurosurgeryhoitotyöDemography
researchProduct

Role of serotonin in central dopamine dysfunction

2010

The interaction between serotonin (5-HT) and dopamine (DA)-containing neurons in the brain is a research topic that has raised the interest of many scientists working in the field of neuroscience since the first demonstration of the presence of monoamine-containing neurons in the mid 1960. The bulk of neuroanatomical data available clearly indicate that DA-containing neurons in the brain receive a prominent innervation from serotonin (5-hydroxytryptamine, 5-HT) originating in the raphe nuclei of the brainstem. Compelling electrophysiological and neurochemical data show that 5-HT can exert complex effects on the activity of midbrain DA neurons mediated by its various receptor subtypes. The m…

Mesocorticolimbic DA systemNigrostriatal DA systemReceptor Serotonin 5-HTParkinson's diseaseBrain microdialysisAntidepressantDopaminergic functionAntidepressantsSettore BIO/09 - Fisiologia5-HT receptorAntipsychoticParkinson diseaseMicrodialysinervous systemSingle cell recordingDrug addictionAntidepressants;Antipsychotics;Dopaminergic function;Drug addiction;5-HT receptors;Mesocorticolimbic DA system;Microdialysis;Nigrostriatal DA system;Parkinson disease;Single cell recordingAntipsychotic drugs
researchProduct

Use of amitriptyline for the treatment of chronic tension-type headache : review of the literature

2008

Amitriptyline is a tricyclic antidepressant, considered the treatment of choice for different types of chronic pain, including chronic myofascial pain. Its antinociceptive property is independent of its antidepressant effect. Although its analgesic mechanism is not precisely known, it is believed that the serotonin reuptake inhibition in the central nervous system plays a fundamental role in pain control. Although this medication is widely used in the prevention of chronic tension-type headache, few studies have investigated the efficacy of this treatment and the published results are contradictory. The objective of this article was to review the literature published on the use of amitripty…

Síndrome de dolor miofascialTractament del dolorMyofascial pain syndromesUNESCO::CIENCIAS MÉDICASPain treatmentAntidepressiusAntidepressants:CIENCIAS MÉDICAS [UNESCO]
researchProduct

The use of tricyclic antidepressants in the treatment of temporomandibular joint disorders: systematic review of the literature of the last 20 years

2009

Many therapies have been proposed for the management of temporomandibular disorders, including the use of different drugs. However, lack of knowledge about the mechanisms behind the pain associated with this pathology, and the fact that the studies carried out so far use highly disparate patient selection criteria, mean that results on the effectiveness of the different medications are inconclusive. This study makes a systematic review of the literature published on the use of tricyclic antidepressants for the treatment of temporomandibular disorders, using the SORT criteria (Strength of recommendation taxonomy) to consider the level of scientific evidence of the different studies. Followin…

Temporomandibular joint disordersUNESCO::CIENCIAS MÉDICASAntidepressiusAntidepressants:CIENCIAS MÉDICAS [UNESCO]Malalties de l'articulació temporomandibular
researchProduct

Need adapted use of medication in the open dialogue approach for psychosis : a descriptive longitudinal cohort study

2022

Background The open dialogue (OD) approach includes the need-adapted use of psychiatric medication in treating first-episode psychosis (FEP), but there is limited information on how psychiatric medications are actually used in OD-based services. This study aims to analyse long-term medication dispensing patterns among FEP cohort treated according to the OD. Methods The OD cohort consisted of people who received treatment for FEP in the Finnish Western Lapland catchment area at a time of OD implementation (n=61). The comparison group included people whose FEP treatment commenced outside the catchment area during the mid-1990s (n=1378). Data were gathered from national registers from onset to…

anxiolyticsskitsofreniapsykoositrisk–benefit ratioAntidepressantspitkittäistutkimusAvoimen dialogin hoitomallischizophreniaPsychiatry and Mental healthantipsychoticspsykiatrinen hoitomielenterveyshäiriötopen dialogmasennuslääkkeetODkohorttitutkimusbentsodiatsepiinitneuroleptit
researchProduct

Pharmacological treatment of burning mouth syndrome : a review and update

2007

Burning mouth syndrome (BMS) is defined as a burning sensation in the tongue or in any other region of the oral mucosa, in the absence of specific oral lesions. The present study reviews the pharmacological treatments used in the last 10 years to reduce the symptoms of BMS, and assesses the efficacy and safety of pharmacological interventions destined to alleviate the symptoms of BMS. To this effect, searches were made in the following databases: Micromedex®, Cochrane Database® and PubMed®, crossing the following key words: drug, treatment, clinical trial, pain management, and burning mouth syndrome. The searches were limited to articles published in the last 10 years in English or Spanish,…

clinical trialstreatmentantidepresivoseducationdigestive oral and skin physiologyBurning mouth syndrome:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasestratamientoanalgésicosantidepressantsensayos clínicosUNESCO::CIENCIAS MÉDICASanalgesicscasos clínicosclinical casesSíndrome de boca ardiente
researchProduct

A dance movement therapy group for depressed adult patients in a psychiatric outpatient clinic: effects of the treatment

2015

We were interested in investigating the effects of dance movement therapy (DMT) in a psychiatric outpatient clinic with patients diagnosed with depression. DMT aims to engage the patients in physical and verbal exploration of their experiences generated in movement based interaction. The assumption was that DMT, which includes both physical engagement as well as emotional and social exploration, would alleviate the mood and psychiatric symptoms. All adult patients (n = 33) included in the study received treatment as usual (TAU). Twenty-one patients participated in a 12-session DMT group intervention, and the remaining 12 patients chose to take TAU only. The majority of the patients suffered…

dance movement therapymedicine.medical_specialtyDancemedicine.medical_treatmentlcsh:BF1-990Psychological interventionpsychiatric outpatient clinicGroup psychotherapyIntervention (counseling)OutpatientsOutpatient clinicMedicinePsychologyPsychiatryDepression (differential diagnoses)ta515General PsychologyOriginal ResearchAdult patientsbusiness.industrygroup therapylcsh:PsychologyMoodryhmäterapiaantidepressantsdepressiontreatment outcomebusinessFrontiers in Psychology
researchProduct

Brain Functional Effects of Psychopharmacological Treatment in Major Depression: A Focus on Neural Circuitry of Affective Processing

2015

In the last two decades, neuroimaging research has reached a much deeper understanding of the neurobiological underpinnings of major depression (MD) and has converged on functional alterations in limbic and prefrontal neural networks, which are mainly linked to altered emotional processing observed in MD patients. To date, a considerable number of studies have sought to investigate how these neural networks change with pharmacological antidepressant treatment. In the current review, we therefore discuss results from a) pharmacological functional magnetic resonance imaging (fMRI) studies investigating the effects of selective serotonin or noradrenalin reuptake inhibitors on neural activation…

major depression.EmotionsEmotional processingArticleNeuroimagingbrain activitymedicineBiological neural networkAnimalsHumansPharmacology (medical)Depression (differential diagnoses)PharmacologyDepressive Disorder Majormedicine.diagnostic_testDepressionBrainMagnetic resonance imagingGeneral MedicineAntidepressantsMagnetic Resonance ImagingAntidepressive AgentsPsychiatry and Mental healthNeurologyAntidepressantNeurology (clinical)PsychologyReuptake inhibitorFunctional magnetic resonance imagingClinical psychologyCurrent Neuropharmacology
researchProduct